Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Research Funding Reaccreditation topic
No spam. Unsubscribe anytime.
Rutgers leaders warn of federal research funding uncertainty and outline accreditation and governance steps
Summary
President Jonathan Holloway and university leaders told the Board Feb. 18 they are monitoring federal actions affecting research funding, including joining litigation over proposed NIH cuts, and reported on reaccreditation planning and Senate oversight to track funding disruptions for researchers.
President Jonathan Holloway told the Board that Rutgers is actively monitoring federal developments that could affect research funding and that the university has taken legal action alongside other states to seek injunctive relief against proposed National Institutes of Health funding cuts; a temporary restraining order followed that effort.
Holloway told governors that university leadership remains focused on Rutgers’ mission and on keeping students, faculty and staff informed as the federal landscape evolves. He also noted institutional successes, including three students named Schwarzman Scholars, and provided updates on enrollment and his recent Budget Address.
Board members and committee chairs reported related concerns during committee briefings. Dr. Prabhas V. Moghe, Executive Vice President for Academic Affairs, provided a detailed update on the Middle States Commission on Higher Education (MSCHE) reaccreditation self-study process, noting the next site visit is expected in 2027 and outlining the self-study timeline and institutional priorities that will guide the review. The University Senate, represented by Lucille Foster, said it adopted a resolution urging creation of an ad-hoc shared-governance committee to monitor stop-work notifications and funding delays affecting Rutgers researchers.
Committee chairs said the university has been reviewing potential impacts of recent federal executive orders, and that campus leaders are preparing processes to protect academic freedom and research continuity. The Board did not take formal action beyond the information updates and committee endorsements reported in consent materials.
The Board's next steps include periodic MSCHE updates to committee and university forums and continued coordination between administration, the Senate, and committees to track federal funding developments.
